Refine
Has Fulltext
- yes (54)
Is part of the Bibliography
- yes (54)
Year of publication
Document Type
- Journal article (52)
- Other (1)
- Preprint (1)
Keywords
- magnetic resonance imaging (7)
- MRI (3)
- arthrography (3)
- giant cell arteritis (3)
- CT angiography (2)
- PET/CT (2)
- X-ray computed (2)
- computed tomography (2)
- deep learning (2)
- dual-energy CT (2)
- endovascular (2)
- fracture (2)
- lung (2)
- machine learning (2)
- multiple myeloma (2)
- photon-counting (2)
- preclinical research (2)
- prostate cancer (2)
- radiology (2)
- radiomics (2)
- tomography (2)
- 1H-Magnetic resonance spectroscopy (1H-MRS) (1)
- 2D-perfusion angiography (1)
- 3D printing (1)
- 3 T (1)
- Applied physics (1)
- Arthrography (1)
- Atherosclerosis, intracranial arteries (1)
- Biomedical engineering (1)
- CMR (1)
- CT (1)
- CT-angiography (1)
- Cancellous bone (1)
- Computed axial tomography (1)
- Cone-beam computed tomography (1)
- Covid-19 (1)
- DSA (1)
- Deep learning (1)
- Diagnose (1)
- Diagnostic medicine (1)
- Dixon (1)
- EULAR guidelines (1)
- Elbow (1)
- Elbow joint (1)
- Extracellular volume (1)
- Fats (1)
- GCA (1)
- Giant cell arteritis (GCA (1)
- Glukokortikoide (1)
- Glukokortikoideinsparende Therapie (1)
- Imaging (1)
- Imaging techniques (1)
- Inflammatory diseases (1)
- L-arginine (1)
- Large vessel vasculitides (LVV) (1)
- MOLLI (1)
- MR angiography (1)
- Magnetic resonance imaging(MRI) (1)
- Mastoid process (1)
- Methotrexat (1)
- Methotrexate (1)
- Multidetector computed tomography (1)
- Myocardial infarction (1)
- NMR relaxation (1)
- PMR (1)
- PSMA (1)
- PSMA-RADS (1)
- PTA (1)
- Radiation exposure (1)
- Riesenzellarteriitis (1)
- SASHA (1)
- ST-elevation myocardial infarction (1)
- Scar (1)
- Segmentation (1)
- ShMOLLI (1)
- Soft tissues (1)
- T1 mapping (1)
- Therapie (1)
- Tocilizumab (1)
- Tomography (1)
- Triangular fibrocartilage (1)
- VIBE (1)
- Vasculitis (1)
- Wrist (1)
- X-ray radiography (1)
- [18F]FDG PET/CT (1)
- \(^{18}\)F-PSMA-1007 (1)
- abdominal imaging (1)
- algorithms (1)
- angiography (1)
- ankle (1)
- aorta (1)
- aortic dissection (1)
- arteriitis temporal arteriitis (1)
- blood coagulation factor XIII (1)
- bone (1)
- bone remineralization (1)
- breast cancer imaging (1)
- breath-hold (1)
- c-reactive protein (1)
- cancellous bone (1)
- cancer imaging (1)
- carcinoma (1)
- cardiac (1)
- cardiac magnetic resonance imaging (1)
- cardiovascular magnetic resonance (CMR) (1)
- cartilage (1)
- central nervous system (1)
- cerebrospinal fluid (1)
- chiasma antebrachii (1)
- chronic mesenteric ischemia (1)
- classification (1)
- clinical application (1)
- cold pressor test (1)
- color-coded (1)
- color-coding (1)
- complication aortic-aneurysm (1)
- computational neural networks (1)
- computed tomography angiography (CTA) (1)
- cone-beamcomputed tomography (1)
- confidence (1)
- continuous extracorporeal femoral perfusion model (1)
- contrast media (1)
- contrast-enhanced ultrasound (1)
- conventional imaging (1)
- convolution kernel (1)
- coracohumeral distance (1)
- coracohumeral impingement (1)
- coronary arteries (1)
- corpus cavernosum (1)
- correction (1)
- corticosteroid treatment (1)
- cross-sectional imaging (1)
- data acquisition (1)
- diagnosis (1)
- diffusion weighted mri (1)
- digital subtraction angiography (1)
- digital subtraction angiography (DSA) (1)
- double-blind (1)
- dual-energy (1)
- dual-source CT (1)
- embolism/thrombosis (1)
- encephalopathy (1)
- endotheliitis (1)
- endothelium (1)
- endovascular treatment (1)
- erythrocyte sedimentation-rate (1)
- experimental models of disease (1)
- extramedullary hematopoiesis (1)
- extremities (1)
- femoral arteries (1)
- fenestration (1)
- flexor digitorum superficialis (1)
- flexor tendon (1)
- fractures, bone (1)
- free‐breathing (1)
- gadoxetic acid (1)
- gender (1)
- glenoid (1)
- glucocorticoid-sparing agents (1)
- glucocorticoids (1)
- healing and remodelling processes (1)
- high risk (1)
- image analysis (1)
- image processing (1)
- image segmentation (1)
- in vivo imaging (1)
- inflammation (1)
- intravascular ultrasound (IVUS) (1)
- joint instability (1)
- large artery vasculitis (1)
- large-vessel vasculitis (1)
- lymphatic metastasis (1)
- medical research (1)
- mesenteric stenting (1)
- metabolism (1)
- musculoskeletal system (1)
- myocardial perfusion (1)
- myocardium (1)
- neoadjuvant therapies (1)
- nnU-net (1)
- non-small-cell lung (1)
- novel human cadaveric perfusion model (1)
- obesity (1)
- ocular manifestations (1)
- ophthalmic artery (1)
- optic nerve (1)
- orbit (1)
- penile thrombosis (1)
- photon-counting CT (1)
- photon-counting computed tomography (CT) (1)
- photon-counting-detector CT (1)
- polymyalgia rheumatica (1)
- polymyalgia-rheomatica (1)
- positive nodal status (1)
- post-neoadjuvant therapies (1)
- prestyloid recess (1)
- priapism (1)
- pulmonary arteries (1)
- pulmonary embolism (1)
- radial (1)
- radiation dosage (1)
- radiation dose (1)
- radiation dose reduction (1)
- radiography (1)
- recurrence (1)
- relaxation (physics) (1)
- relaxation time (1)
- reliability (1)
- renal artery (1)
- reproducibility (1)
- reproducibility of results (1)
- rotator cuff tear (1)
- salvage radiotherapy (1)
- scapula (1)
- self‐gated (1)
- semantic segmentation (1)
- signal to noise ratio (1)
- small pixel effect (1)
- small-cell lung (1)
- smoking (1)
- spectral CT (1)
- spectral imaging (1)
- spectral shaping (1)
- spleen (1)
- staging (1)
- standard (1)
- standardized reporting system (1)
- stenosis (1)
- subscapularis tear (1)
- systemic vasculitides (1)
- therapy (1)
- thorax (1)
- tin prefiltration (1)
- translational research (1)
- triangular fibrocartilage (1)
- triangular fibrocartilage complex (1)
- triglycerides (1)
- tumor burden (1)
- ultra-low-dose CT (1)
- ultrahigh resolution (1)
- undersampling (1)
- urinary calculi (1)
- vasa vasorum (1)
- vascular (1)
- vasculature (1)
- vasculitis (1)
- vertebral artery (1)
- virtual non-contrast (1)
- wave‐CAIPI (1)
- whole-body imaging (1)
- workflow (1)
- wrist (1)
- x-ray computed (1)
Institute
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (49)
- Institut für Anatomie und Zellbiologie (10)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (6)
- Klinik und Poliklinik für Nuklearmedizin (5)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (4)
- Medizinische Klinik und Poliklinik II (4)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (3)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (3)
- Medizinische Klinik und Poliklinik I (3)
- Physikalisches Institut (3)
Objectives: Positron emission tomography (PET) is currently considered the non-invasive reference standard for lymph node (N-)staging in lung cancer. However, not all patients can undergo this diagnostic procedure due to high costs, limited availability, and additional radiation exposure. The purpose of this study was to predict the PET result from traditional contrast-enhanced computed tomography (CT) and to test different feature extraction strategies. Methods: In this study, 100 lung cancer patients underwent a contrast-enhanced \(^{18}\)F-fluorodeoxyglucose (FDG) PET/CT scan between August 2012 and December 2019. We trained machine learning models to predict FDG uptake in the subsequent PET scan. Model inputs were composed of (i) traditional “hand-crafted” radiomics features from the segmented lymph nodes, (ii) deep features derived from a pretrained EfficientNet-CNN, and (iii) a hybrid approach combining (i) and (ii). Results: In total, 2734 lymph nodes [555 (20.3%) PET-positive] from 100 patients [49% female; mean age 65, SD: 14] with lung cancer (60% adenocarcinoma, 21% plate epithelial carcinoma, 8% small-cell lung cancer) were included in this study. The area under the receiver operating characteristic curve (AUC) ranged from 0.79 to 0.87, and the scaled Brier score (SBS) ranged from 16 to 36%. The random forest model (iii) yielded the best results [AUC 0.871 (0.865–0.878), SBS 35.8 (34.2–37.2)] and had significantly higher model performance than both approaches alone (AUC: p < 0.001, z = 8.8 and z = 22.4; SBS: p < 0.001, z = 11.4 and z = 26.6, against (i) and (ii), respectively). Conclusion: Both traditional radiomics features and transfer-learning deep radiomics features provide relevant and complementary information for non-invasive N-staging in lung cancer.
Magnetic Particle Imaging (MPI) is a promising new tomographic modality for fast as well as three-dimensional visualization of magnetic material. For anatomical or structural information an additional imaging modality such as computed tomography (CT) is required. In this paper, the first hybrid MPI-CT scanner for multimodal imaging providing simultaneous data acquisition is presented.
The aim of this study was to explore the applicability of fast MR techniques to routine paediatric abdominopelvic MRI at 1.5 Tesla. "Controlled Aliasing in Parallel Imaging Results in Higher Acceleration-" (CAIPIRINHA-) accelerated contrast-enhanced-T1w 3D FLASH imaging was compared to standard T1w 2D FLASH imaging with breath-holding in 40 paediatric patients and to respiratory-triggered T1w TSE imaging in 10 sedated young children. In 20 nonsedated patients, we compared T2w TIRM to fat-saturated T2w HASTE imaging. Two observers performed an independent and blinded assessment of overall image quality. Acquisition time was reduced by the factor of 15 with CAIPIRINHA-accelerated T1w FLASH and by 7 with T2w HASTE. With CAIPIRINHA and with HASTE, there were significantly less motion artefacts in nonsedated patients. In sedated patients, respiratory-triggered T1w imaging in general showed better image quality. However, satisfactory image quality was achieved with CAIPIRINHA in two sedated patients where respiratory triggering failed. In summary, fast scanning with CAIPIRINHA and HASTE presents a reliable high quality alternative to standard sequences in paediatric abdominal MRI. Paediatric patients, in particular, benefit greatly from fast image acquisition with less breath-hold cycles or shorter sedation.
Objective:
Over the past decade, myocardial triglyceride content has become an accepted biomarker for chronic metabolic and cardiac disease. The purpose of this study was to use proton (hydrogen 1)-magnetic resonance spectroscopy (\(^{1}\)H-MRS) at 3Tesla (3 T) field strength to assess potential gender-related differences in myocardial triglyceride content in healthy individuals.
Methods:
Cardiac MR imaging was performed to enable accurate voxel placement and obtain functional and morphological information. Double triggered (i.e., ECG and respiratory motion gating) \(^{1}\)H-MRS was used to quantify myocardial triglyceride levels for each gender. Two-sample t-test and Mann-Whitney U-test were used for statistical analyses.
Results:
In total, 40 healthy volunteers (22 male, 18 female; aged >18 years and age matched) were included in the study. Median myocardial triglyceride content was 0.28% (interquartile range [IQR] 0.17–0.42%) in male and 0.24% (IQR 0.14–0.45%) in female participants, and no statistically significant difference was observed between the genders. Furthermore, no gender-specific difference in ejection fraction was observed, although on average, male participants presented with a higher mean ± SD left ventricular mass (136.3 ± 25.2 g) than female participants (103.9 ± 16.1 g).
Conclusions:
The study showed that \(^{1}\)H-MRS is a capable, noninvasive tool for acquisition of myocardial triglyceride metabolites. Myocardial triglyceride concentration was shown to be unrelated to gender in this group of healthy volunteers.
Background
Salvage radiotherapy (SRT) is clinically established in prostate cancer (PC) patients with PSA persistence or biochemical relapse (BCR) after prior radical surgery. PET/CT imaging prior to SRT may be performed to localize disease recurrence. The recently introduced \(^{68}\)Ga-PSMA outperforms other PET tracers for detection of recurrence and is therefore expected also to impact radiation planning.
Forty-five patients with PSA persistence (16 pts) or BCR (29 pts) after prior prostatectomy, scheduled to undergo SRT of the prostate bed, underwent \(^{68}\)Ga-PSMA PET/CT. The median PSA level was 0.67 ng/ml. The impact of \(^{68}\)Ga-PSMA PET/CT on the treatment decision was assessed. Patients with oligometastatic (≤5 lesions) PC underwent radiotherapy (RT), with the extent of the RT area and dose escalation being based on PET positivity.
Results
Suspicious lesions were detected in 24/45 (53.3 %) patients. In 62.5 % of patients, lesions were only detected by 68Ga-PSMA PET. Treatment was changed in 19/45 (42.2 %) patients, e.g., extending SRT to metastases (9/19), administering dose escalation in patients with morphological local recurrence (6/19), or replacing SRT by systemic therapy (2/19). 38/45 (84.4 %) followed the treatment recommendation, with data on clinical follow-up being available in 21 patients treated with SRT. All but one showed biochemical response (mean PSA decline 78 ± 19 %) within a mean follow-up of 8.12 ± 5.23 months.
Conclusions
\(^{68}\)Ga-PSMA PET/CT impacts treatment planning in more than 40 % of patients scheduled to undergo SRT. Future prospective studies are needed to confirm this significant therapeutic impact on patients prior to SRT.
Background
Partial segmental thrombosis of the corpus cavernosum (PSTCC) is a rare disease predominantly occurring in young men. Cardinal symptoms are pain and perineal swelling. Although several risk factors are described in the literature, the exact etiology of penile thrombosis remains unclear in most cases. MRI or ultrasound (US) is usually used for diagnosing this condition.
Case presentation
We report a case of penile thrombosis after left-sided varicocele ligature in a young patient. The diagnosis was established using contrast-enhanced ultrasound (CEUS) and was confirmed by contrast-enhanced magnetic resonance imaging (ceMRI). Successful conservative treatment consisted of systemic anticoagulation using low molecular weight heparin and acetylsalicylic acid.
Conclusion
PSTCC is a rare condition in young men and appears with massive pain and perineal swelling. In case of suspected PSTCC utilization of CEUS may be of diagnostic benefit.
Mapping the longitudinal relaxation time \(T_1\) has widespread applications in clinical MRI as it promises a quantitative comparison of tissue properties across subjects and scanners. Due to the long scan times of conventional methods, however, the use of quantitative MRI in clinical routine is still very limited. In this work, an acceleration of Inversion-Recovery Look-Locker (IR-LL) \(T_1\) mapping is presented. A model-based algorithm is used to iteratively enforce an exponential relaxation model to a highly undersampled radially acquired IR-LL dataset obtained after the application of a single global inversion pulse. Using the proposed technique, a \(T_1\) map of a single slice with 1.6mm in-plane resolution and 4mm slice thickness can be reconstructed from data acquired in only 6s. A time-consuming segmented IR experiment was used as gold standard for \(T_1\) mapping in this work. In the subsequent validation study, the model-based reconstruction of a single-inversion IR-LL dataset exhibited a \(T_1\) difference of less than 2.6% compared to the segmented IR-LL reference in a phantom consisting of vials with \(T_1\) values between 200ms and 3000ms. In vivo, the \(T_1\) difference was smaller than 5.5% in WM and GM of seven healthy volunteers. Additionally, the \(T_1\) values are comparable to standard literature values. Despite the high acceleration, all model-based reconstructions were of a visual quality comparable to fully sampled references. Finally, the reproducibility of the \(T_1\) mapping method was demonstrated in repeated acquisitions. In conclusion, the presented approach represents a promising way for fast and accurate \(T_1\) mapping using radial IR-LL acquisitions without the need of any segmentation.
Background: Giant cell arteritis (GCA) is the most common systemic vasculitis in persons aged 50 and above (incidence, 3.5 per 100 000 per year). It affects cranial arteries, the aorta, and arteries elsewhere in the body, e.g., in the limbs.
Methods: We selectively review the pertinent literature, including guidelines and recommendations from Germany and abroad.
Results: The typical symptoms of new-onset GCA are bi-temporal headaches, jaw claudiacation, scalp tenderness, visual disturbances, systemic symptoms such as fever and weight loss, and polymyalgia. The diagnostic assessment comprises laboratory testing (erythrocyte sedimentation rate, C-reactive protein), imaging studies (duplex sonography, high-resolution magnetic resonance imaging, positron-emission tomography), and temporal artery biopsy. The standard treatment is with corticosteroids (adverse effects: diabetes mellitus, osteoporosis, cataract, arterial hypertension). A meta-analysis of three randomized controlled trials led to a recommendation for treatment with methotrexate to lower the recurrence rate and spare steroids. Patients for whom methotrexate is contraindicated or who cannot tolerate the drug can be treated with azathioprine instead.
Conclusion: Giant cell arteritis, if untreated, progresses to involve the aorta and its collateral branches, leading to various complications. Late diagnosis and treatment can have serious consequences, including irreversible loss of visual function.
Aims Acute myocardial infarction (MI) is the major cause of chronic heart failure. The activity of blood coagulation factor XIII (FXIIIa) plays an important role in rodents as a healing factor after MI, whereas its role in healing and remodelling processes in humans remains unclear. We prospectively evaluated the relevance of FXIIIa after acute MI as a potential early prognostic marker for adequate healing.
Methods and results This monocentric prospective cohort study investigated cardiac remodelling in patients with ST-elevation MI and followed them up for 1 year. Serum FXIIIa was serially assessed during the first 9 days after MI and after 2, 6, and 12 months. Cardiac magnetic resonance imaging was performed within 4 days after MI (Scan 1), after 7 to 9 days (Scan 2), and after 12 months (Scan 3). The FXIII valine-to-leucine (V34L) single-nucleotide polymorphism rs5985 was genotyped. One hundred forty-six patients were investigated (mean age 58 ± 11 years, 13% women). Median FXIIIa was 118 % (quartiles, 102–132%) and dropped to a trough on the second day after MI: 109%(98–109%; P < 0.001). FXIIIa recovered slowly over time, reaching the baseline level after 2 to 6 months and surpassed baseline levels only after 12 months: 124 % (110–142%). The development of FXIIIa after MI was independent of the genotype. FXIIIa on Day 2 was strongly and inversely associated with the relative size of MI in Scan 1 (Spearman’s ρ = –0.31; P = 0.01) and Scan 3 (ρ = –0.39; P < 0.01) and positively associated with left ventricular ejection fraction: ρ = 0.32 (P < 0.01) and ρ = 0.24 (P = 0.04), respectively.
Conclusions FXIII activity after MI is highly dynamic, exhibiting a significant decline in the early healing period, with reconstitution 6 months later. Depressed FXIIIa early after MI predicted a greater size of MI and lower left ventricular ejection fraction after 1 year. The clinical relevance of these findings awaits to be tested in a randomized trial.
Due to the low frequency of abnormalities affecting the spleen, this organ is often overlooked during radiological examinations. Here, we report on the unexpected finding, that the spleen signal on diffusion-weighted MRI (DW-MRI) is associated with clinical parameters in patients with plasma cell dyscrasias. Methods: We investigated the spleen signal on DW-MRI together with clinical and molecular parameters in 295 transplant-eligible newly diagnosed Multiple Myeloma (NDMM) patients and in 72 cases with monoclonal gammopathy of undetermined significance (MGUS). Results: Usually, the spleen is the abdominal organ with the highest intensities on DW-MRI. Yet, significant signal loss on DW-MRI images was seen in 71 of 295 (24%) NDMM patients. This phenomenon was associated with the level of bone marrow plasmacytosis (P=1x10(-10)) and International Staging System 3 (P=0.0001) but not with gain(1q), and del(17p) or plasma cell gene signatures. The signal was preserved in 72 individuals with monoclonal gammopathy of undetermined significance and generally re-appeared in MM patients responding to treatment, suggesting that lack of signal reflects increased tumor burden. While absence of spleen signal in MM patients with high risk disease defined a subgroup with very poor outcome, re-appearance of the spleen signal after autologous stem cell transplantation was seen in patients with improved outcome. Our preliminary observation suggests that extramedullary hematopoiesis in the spleen is a factor that modifies the DW-MRI signal of this organ. Conclusions: The DW-MRI spleen signal is a promising marker for tumor load and provides prognostic information in MM.